• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

CD151, A Novel Host Factor of Nuclear Export Signaling in Influenza Virus Infection

tetano

Editor, Senior Moderator
J Allergy Clin Immunol. 2017 Dec 20. pii: S0091-6749(17)32920-2. doi: 10.1016/j.jaci.2017.11.032. [Epub ahead of print]
[h=1]CD151, A Novel Host Factor of Nuclear Export Signaling in Influenza Virus Infection.[/h] Qiao Y[SUP]1[/SUP], Yan Y[SUP]2[/SUP], Tan KS[SUP]2[/SUP], Tan SS[SUP]1[/SUP], Seet JE[SUP]3[/SUP], Arumugam TV[SUP]1[/SUP], Chow VT[SUP]4[/SUP], Wang Y[SUP]5[/SUP], Tran T[SUP]6[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] [h=4]BACKGROUND:[/h] Despite advances in our understanding of the mechanisms of influenza A virus (IAV) infection, the crucial virus-host interactions during the viral replication cycle still remain incomplete. Tetraspanin CD151 is highly expressed in the human respiratory tract, but its pathological role in IAV infection is unknown.
[h=4]OBJECTIVES:[/h] To characterize the functional role and mechanisms of action of CD151 in IAV infection of the upper and lower respiratory tracts with H1N1 and H3N2 strains.
[h=4]METHODS:[/h] We used CD151-null mice in an in vivo model of IAV infection and clinical donor samples of in vitro-differentiated human nasal epithelial cells cultured at air-liquid interface.
[h=4]RESULTS:[/h] As compared with wild-type infected mice, CD151-null infected mice exhibited significant reduction in virus titer and improvement in survival that is associated with pronounced host anti-viral response and inflammasome activation together with accelerated lung repair. Interestingly, we show that CD151 complexes newly synthesized viral proteins with host nuclear export proteins and stabilizes microtubule complexes which are key processes necessary for the polarized trafficking of viral progeny to the host plasma membrane for assembly.
[h=4]CONCLUSIONS:[/h] Our results provide new mechanistic insights into our understanding of IAV infection. We show that CD151 is a critical novel host factor of nuclear export signaling whereby the IAV nuclear export utilizes it to complement its own nuclear export proteins (a site not targeted by current therapy), making this regulation unique and holds promise for the development of novel alternative/complementary strategies to reduce IAV severity.
Copyright ? 2017 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.


[h=4]KEYWORDS:[/h] CD151; IAV severity; host innate immunity; inflammasome; influenza A virus (IAV); nuclear export

PMID: 29274410 DOI: 10.1016/j.jaci.2017.11.032
 
Back
Top Bottom